Kwok Pui Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kwok Pui Choi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Chin Meng Khoo
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore
1 shared publication - E. Shyong Tai
Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
1 shared publication - Guoshou Teo
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore
1 shared publication - Hiromi W. L. Koh
Institute of Molecular and Cell Biology Agency for Science Technology and Research (A*STAR) Singapore Singapore
1 shared publication - Hongbao Zhang
School of Data Science, The Chinese University of Hong Kong, Shenzhen, Shenzhen, CHINA
1 shared publication - Hyungwon Choi
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
1 shared publication
Latest Publications
- Open Access
- 21 July 2025
- Published by Springer Nature in Statistics in Biosciences
- p. 1-31
Adaptive Parameter Tuning of Evolutionary Computation Algorithms
Herein, we consider the long-standing problem of adaptive parameter tuning and propose a novel approach, with optimal properties that achieve oracle bounds, to meet the challenges in new important applications in the big-data multi-cloud era.
- 21 July 2025
- Published by Springer Nature in Statistics in Biosciences
- p. 1-31
Open AccessAdaptive Parameter Tuning of Evolutionary Computation Algorithms
Herein, we consider the long-standing problem of adaptive parameter tuning and propose a novel approach, with optimal properties that achieve oracle bounds, to meet the challenges in new important applications in the big-data multi-cloud era.
- 19 May 2025
- Published by Springer Nature in Statistics in Biosciences
- p. 1-20
From Doob and Feller to Stein’s Method and Back
- 19 May 2025
- Published by Springer Nature in Statistics in Biosciences
- p. 1-20
From Doob and Feller to Stein’s Method and Back
- Open Access
- 8 April 2021
- Published by MDPI AG in Metabolites
- Vol. 11 (4) , 228
Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy
We conducted untargeted metabolomics analysis of plasma samples from a cross-sectional case–control study with 30 healthy controls, 30 patients with diabetes mellitus and normal renal function (DM-N), and 30 early diabetic nephropathy (DKD) patients using liquid chromatography-mass spectrometry (LC-MS). We employed two different modes of MS acquisition on a high-resolution MS instrument for identification and semi-quantification, and analyzed data using an advanced multivariate method for prioritizing differentially abundant metabolites. We obtained semi-quantification data for 1088 unique compounds (~55% lipids), excluding compounds that may be either exogenous compounds or treated as medication. Supervised classification analysis over a confounding-free partial correlation network shows that prostaglandins, phospholipids, nucleotides, sugars, and glycans are elevated in the DM-N and DKD patients, whereas glutamine, phenylacetylglutamine, 3-indoxyl sulfate, acetylphenylalanine, xanthine, dimethyluric acid, and asymmetric dimethylarginine are increased in DKD compared to DM-N. The data recapitulate the well-established plasma metabolome changes associated with DM-N and suggest uremic solutes and oxidative stress markers as the compounds indicating early renal function decline in DM patients.
- 8 April 2021
- Published by MDPI AG in Metabolites
- Vol. 11 (4) , 228
Open AccessPlasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy
We conducted untargeted metabolomics analysis of plasma samples from a cross-sectional case–control study with 30 healthy controls, 30 patients with diabetes mellitus and normal renal function (DM-N), and 30 early diabetic nephropathy (DKD) patients using liquid chromatography-mass spectrometry (LC-MS). We employed two different modes of MS acquisition on a high-resolution MS instrument for identification and semi-quantification, and analyzed data using an advanced multivariate method for prioritizing differentially abundant metabolites. We obtained semi-quantification data for 1088 unique compounds (~55% lipids), excluding compounds that may be either exogenous compounds or treated as medication. Supervised classification analysis over a confounding-free partial correlation network shows that prostaglandins, phospholipids, nucleotides, sugars, and glycans are elevated in the DM-N and DKD patients, whereas glutamine, phenylacetylglutamine, 3-indoxyl sulfate, acetylphenylalanine, xanthine, dimethyluric acid, and asymmetric dimethylarginine are increased in DKD compared to DM-N. The data recapitulate the well-established plasma metabolome changes associated with DM-N and suggest uremic solutes and oxidative stress markers as the compounds indicating early renal function decline in DM patients.